Novo Holdings A/S’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Novo Holdings A/S’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,027,091	Closed	-$25.5M	–	19
2016 Q2	$25.5M	Sell	2,027,091 -254,314	-11%	-$2.37M	2.67%	7
2016 Q1	$18.7M	Sell	2,281,405 -190,000	-8%	-$1.43M	2.05%	7
2015 Q4	$24.8M	Sell	2,471,405 -225,000	-8%	-$2.34M	2.39%	6
2015 Q3	$26M	Hold	2,696,405	–	–	2.69%	6
2015 Q2	$46.5M	Buy	+2,696,405	New	+$39.4M	3.35%	9

Other funds holding TBRA

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Novo Holdings A/S's TBRA Position: Q3 2016 in Review

Novo Holdings A/S sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016, closing a stake of 2,027,091 shares — an estimated $25.5M sold.

Novo Holdings A/S first reported a position in TBRA in Q2 2015 and held it in 5 quarters. The position peaked at $46.5M in Q2 2015. 68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

Novo Holdings A/S reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Novo Holdings A/S sold 2,027,091 Tobira Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $25.5M.
Novo Holdings A/S first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
Novo Holdings A/S's Tobira Therapeutics, Inc. Common Stock position peaked at $46.5M in Q2 2015.
68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Novo Holdings A/S's 13F filing for Q3 2016, filed 14 Nov 2016.